Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News KDA Group Inc V.KDA

Alternate Symbol(s):  KDAGF

Healthcare
KDA Group Inc. is a Canada-based company focused on the development and marketing of its technological products and specialized software solutions for the healthcare market. The Company operates through Pharmaceutical Technology segment. It is focused on developing its technological products across four different platforms: KRX Medical, KRX Dental, KRX Cannabinoid and Adherize (ADRX). The KRX... see more

Recent & Breaking News (TSXV:KDA)

KDA Group Announces the Appointment of the Honorable Jean Charest as New Strategic Advisor

TheNewsWire 4 days ago

KDA Group Launches Medherize for Specialized Metastatic Breast Cancer Treatment Management

TheNewsWire August 1, 2024

KDA Group Announces the Development of Medherize, a New Clinical Management Solution for Specialized Medications for Breast Cancer

TheNewsWire June 12, 2024

KDA Group Announces Results of Shareholders' Annual General and Special Meeting

TheNewsWire May 17, 2024

Adherize+ Platform Update

TheNewsWire March 21, 2024

KDA Group Completes Debt Settlement

TheNewsWire February 29, 2024

KDA Group Announces the Appointments of Yves Marmet as General Manager and Chief Technology Officer and Marie-Helene Pinard as Chief Operating Officer of its Subsidiary Groupe Technologique KDA, and a Debt Settlement

TheNewsWire February 22, 2024

KDA Group Announces Collaboration With Several Pharmacy Banners

TheNewsWire December 20, 2023

ZoomMed Announces Distribution to Its Shareholders of 5 Million Common Shares It Holds in KDA Group

GlobeNewswire December 18, 2023

KDA Group Announces Closing of Private Placement

TheNewsWire December 8, 2023

KDA Group -- Update

TheNewsWire September 22, 2023

KDA Group Announces the Appointment of Michael W. Kinley as Chief Financial Officer

TheNewsWire September 5, 2023

TSX Venture Exchange Stock Maintenance Bulletins

Canada NewsWire August 3, 2023

KDA Group Completes Acquisition of All ZRX Digital Prescriber Proprietary Rights From ZoomMed

TheNewsWire July 28, 2023

KDA Group Announces the Signing of an Agreement with Zoommed Medical Inc. to Expand the Operating Territory of the ZRx Digital Prescriber

TheNewsWire June 30, 2023

KDA Group Announces Debt Repayment and Two Directors' Resignation

TheNewsWire June 29, 2023

KDA Group Completes the Sale of its Subsidiary Agence L.I.V. Inc.

TheNewsWire June 28, 2023

KDA Group Announces Results of Shareholders' Annual General and Special Meeting

TheNewsWire June 28, 2023

KDA Group Announces the Signing of an Agreement for the Sale of its Subsidiary Agence L.I.V. Inc.

TheNewsWire May 29, 2023

TSX Venture Exchange Stock Maintenance Bulletins

Canada NewsWire May 12, 2023